Pipeline Phase Listing Configuration


Therapetic Area : bms:therapeutiic-area/hematology

Tumor : bms:tumor/acute-myeloid-leukemia

Brand Compound Name :

IDHIFA®✦
(enasidenib)

Pipeline Phase Listing Content

Researches and their phases:::

Phase:
bms:phase/phase-3

Research Area/Line of Therapy

Relapsed/Refractory with an IDH2 Mutation

Researches and their phases:::

Phase:
bms:phase/phase-2

Research Area/Line of Therapy

1st line

Researches and their phases:::

Phase:
bms:phase/phase-2

Research Area/Line of Therapy

Newly Diagnosed with an IDH2 Mutation